Lomaira is a brand name for an oral formulation of low-dose, immediate-release insulin human [1]. It is used to improve glycemic control in adults with diabetes mellitus [1]. Lomaira is designed for mealtime insulin coverage [1].
How does Lomaira work?
Lomaira contains insulin human, which is a short-acting insulin [1]. It works by helping glucose move from the bloodstream into cells, where it is used for energy [1]. This process lowers blood glucose levels [1].
What is the difference between Lomaira and other insulins?
Lomaira's key differentiator is its low dosage and immediate-release formulation, intended specifically for mealtime insulin needs [1]. Unlike some other insulins that provide longer-acting glucose control or are administered in higher doses for basal insulin coverage, Lomaira is designed for rapid action around meal times [1].
When does Lomaira's patent expire?
Information regarding the specific patent expiry dates for Lomaira is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [2].
Who manufactures Lomaira?
The manufacturer of Lomaira is likely indicated on product labeling and official prescribing information, often accessible through pharmaceutical databases or the company's official website [1].
What are the potential side effects of Lomaira?
Common side effects associated with Lomaira, like other insulin products, can include hypoglycemia (low blood sugar), weight gain, and injection site reactions [1]. Hypoglycemia is the most frequent adverse event and can manifest with symptoms such as dizziness, sweating, and confusion [1].
What are the risks associated with using Lomaira?
The primary risk associated with Lomaira is hypoglycemia, which can be severe and lead to unconsciousness or seizures if not managed [1]. Other risks include allergic reactions, and changes in potassium levels [1]. It is crucial for patients to monitor their blood sugar closely and follow their healthcare provider's instructions regarding dosage and timing [1].
How is Lomaira prescribed?
Lomaira is a prescription medication and should only be used under the guidance of a qualified healthcare professional [1]. Dosage and administration are tailored to individual patient needs and blood glucose monitoring results [1].
Can Lomaira be used in children?
Currently, Lomaira is indicated for use in adults with diabetes mellitus [1]. Its use in pediatric populations would require specific clinical trials and regulatory approval.